Meeder Asset Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-2,066
| Closed | -$23K | – | 2458 |
|
|
2021
Q3 | $23K | Buy |
2,066
+1,490
| +259% | +$16.6K | ﹤0.01% | 1376 |
|
|
2021
Q2 | $10K | Buy |
+576
| New | +$10K | ﹤0.01% | 1710 |
|
|
2020
Q4 | – | Sell |
-2,522
| Closed | -$33K | – | 2305 |
|
|
2020
Q3 | $33K | Buy |
2,522
+151
| +6% | +$1.98K | ﹤0.01% | 1038 |
|
|
2020
Q2 | $24K | Buy |
2,371
+193
| +9% | +$1.95K | ﹤0.01% | 1097 |
|
|
2020
Q1 | $17K | Buy |
2,178
+1,730
| +386% | +$13.5K | ﹤0.01% | 1318 |
|
|
2019
Q4 | $4K | Sell |
448
-514
| -53% | -$4.59K | ﹤0.01% | 1873 |
|
|
2019
Q3 | $6K | Buy |
962
+474
| +97% | +$2.96K | ﹤0.01% | 1722 |
|
|
2019
Q2 | $8K | Sell |
488
-68
| -12% | -$1.12K | ﹤0.01% | 1540 |
|
|
2019
Q1 | $9K | Sell |
556
-2,149
| -79% | -$34.8K | ﹤0.01% | 1279 |
|
|
2018
Q4 | $32K | Buy |
2,705
+2,476
| +1,081% | +$29.3K | ﹤0.01% | 928 |
|
|
2018
Q3 | $9K | Buy |
+229
| New | +$9K | ﹤0.01% | 1196 |
|